BioSpace News Archive

Acupath Labs a leading provider of sub-specialized anatomic and molecular pathology services, launches the BioFire® FilmArray® GI Panel, a FDA-cleared PCR based panel that tests for 22 of the most common pathogens associated with gastroenteritis, with results in ~ 1 hour.

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will participate at the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023, at 12:15 p.m. ET.

Centinel Spine®, LLC announced that it has entered into a definitive agreement to sell its global Spine Fusion product portfolio and related assets to Silony Medical.

GaiaGift, LLC a leader in the field of birth tissue collection, announces the expansion of its esteemed physician network, offering more opportunities for donors to participate in its remarkable donation program supporting the development of novel cell and gene therapies.

Kubota Vision Inc., a clinical-stage specialty ophthalmology company and a wholly owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., announced the execution of a collaborative research agreement between Kubota Vision and China Medical University Hsinchu Hospital, Department of Ophthalmology, for a study using Kubota Glass in Taiwan, led by Dr. Ying-Shan Chen.

Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® and the ISDD market, is intensifying efforts to combat sepsis misdiagnosis this Sepsis Awareness Month.

Viridian Therapeutics, Inc. announced that multiple abstracts featuring clinical and preclinical data on the Company’s pipeline candidates for the treatment of thyroid eye disease will be presented at the following medical meetings.

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced interim results from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% in adults and children ages 6 years and older with atopic dermatitis.

Life Science Cares is thrilled to announce a new $250,000 partnership with Kura Oncology to provide additional grant funding for educational initiatives in both San Diego and Greater Boston.

Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, announced a series of senior leadership promotions and a new senior appointment, effective immediately.